SIRT1 and cancer: SIRT1, a highly conserved nicotinamide adenosine dinucleotide (NAD+) dependent class III histone deacetylase, is able to interact with and deacetylate c-Myc in cancer cells, which in turn increase its stability and activity (Mao et al., 2011; Menssen et al., 2012).